297 related articles for article (PubMed ID: 35447722)
1. Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema.
Sung CJ; Gupta K; Wang J; Wong AK
Bioengineering (Basel); 2022 Apr; 9(4):. PubMed ID: 35447722
[TBL] [Abstract][Full Text] [Related]
2. Engineering the Lymphatic Network: A Solution to Lymphedema.
Jia W; Hitchcock-Szilagyi H; He W; Goldman J; Zhao F
Adv Healthc Mater; 2021 Mar; 10(6):e2001537. PubMed ID: 33502814
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic Vessels in Regenerative Medicine and Tissue Engineering.
Schaupper M; Jeltsch M; Rohringer S; Redl H; Holnthoner W
Tissue Eng Part B Rev; 2016 Oct; 22(5):395-407. PubMed ID: 27142568
[TBL] [Abstract][Full Text] [Related]
4. Tissue Engineering Strategies for Cancer-Related Lymphedema.
Asaad M; Hanson SE
Tissue Eng Part A; 2021 Apr; 27(7-8):489-499. PubMed ID: 33563108
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic endothelial cell RXRα is critical for 9-cis-retinoic acid-mediated lymphangiogenesis and prevention of secondary lymphedema.
Sung C; Jiao W; Park SY; Cooper M; Bouz A; Choi D; Jung E; Kim G; Hong YK; Wong AK
FASEB J; 2023 Jan; 37(1):e22674. PubMed ID: 36520015
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic Vascular Regeneration: The Next Step in Tissue Engineering.
Huethorst E; Krebber MM; Fledderus JO; Gremmels H; Xu YJ; Pei J; Verhaar MC; Cheng C
Tissue Eng Part B Rev; 2016 Feb; 22(1):1-14. PubMed ID: 26204330
[TBL] [Abstract][Full Text] [Related]
7. Prolymphangiogenic Effects of 9-
Lee GK; Perrault DP; Bouz A; Pourmoussa AJ; Yu R; Kim SJ; Gardner D; Johnson M; Park SY; Park EK; Seong YJN; Lee S; Jung E; Choi D; Hong YK; Wong AK
Lymphat Res Biol; 2022 Dec; 20(6):640-650. PubMed ID: 35584281
[No Abstract] [Full Text] [Related]
8. Review of treatment strategies after lymphadenectomy: from molecular therapeutics to immediate microsurgical lymphatic reconstruction.
Sung C; Wang J; Chang J; Wong AK
J Vasc Surg Venous Lymphat Disord; 2024 Feb; ():101844. PubMed ID: 38316291
[TBL] [Abstract][Full Text] [Related]
9. Lymphedema and therapeutic lymphangiogenesis.
Saito Y; Nakagami H; Kaneda Y; Morishita R
Biomed Res Int; 2013; 2013():804675. PubMed ID: 24222916
[TBL] [Abstract][Full Text] [Related]
10. 9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema.
Choi I; Lee S; Kyoung Chung H; Suk Lee Y; Eui Kim K; Choi D; Park EK; Yang D; Ecoiffier T; Monahan J; Chen W; Aguilar B; Lee HN; Yoo J; Koh CJ; Chen L; Wong AK; Hong YK
Circulation; 2012 Feb; 125(7):872-82. PubMed ID: 22275501
[TBL] [Abstract][Full Text] [Related]
11. Adipose-derived stem cell therapy shows promising results for secondary lymphedema.
Hu LR; Pan J
World J Stem Cells; 2020 Jul; 12(7):612-620. PubMed ID: 32843917
[TBL] [Abstract][Full Text] [Related]
12. Current Advancements in Animal Models of Postsurgical Lymphedema: A Systematic Review.
Hsu JF; Yu RP; Stanton EW; Wang J; Wong AK
Adv Wound Care (New Rochelle); 2022 Aug; 11(8):399-418. PubMed ID: 34128396
[No Abstract] [Full Text] [Related]
13. Lymphatic Tissue Engineering and Regeneration.
Alderfer L; Wei A; Hanjaya-Putra D
J Biol Eng; 2018; 12():32. PubMed ID: 30564284
[TBL] [Abstract][Full Text] [Related]
14. Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy.
Baker A; Kim H; Semple JL; Dumont D; Shoichet M; Tobbia D; Johnston M
Breast Cancer Res; 2010; 12(5):R70. PubMed ID: 20825671
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic Dysfunction, Leukotrienes, and Lymphedema.
Jiang X; Nicolls MR; Tian W; Rockson SG
Annu Rev Physiol; 2018 Feb; 80():49-70. PubMed ID: 29029593
[TBL] [Abstract][Full Text] [Related]
16. Aligned nanofibrillar collagen scaffolds - Guiding lymphangiogenesis for treatment of acquired lymphedema.
Hadamitzky C; Zaitseva TS; Bazalova-Carter M; Paukshto MV; Hou L; Strassberg Z; Ferguson J; Matsuura Y; Dash R; Yang PC; Kretchetov S; Vogt PM; Rockson SG; Cooke JP; Huang NF
Biomaterials; 2016 Sep; 102():259-267. PubMed ID: 27348849
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk Between microRNAs and the Pathological Features of Secondary Lymphedema.
Yusof KM; Groen K; Rosli R; Avery-Kiejda KA
Front Cell Dev Biol; 2021; 9():732415. PubMed ID: 34733847
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration.
Choi I; Lee YS; Chung HK; Choi D; Ecoiffier T; Lee HN; Kim KE; Lee S; Park EK; Maeng YS; Kim NY; Ladner RD; Petasis NA; Koh CJ; Chen L; Lenz HJ; Hong YK
Angiogenesis; 2013 Jan; 16(1):29-44. PubMed ID: 22945845
[TBL] [Abstract][Full Text] [Related]
19. Tissue-engineered lymphatic graft for the treatment of lymphedema.
Kanapathy M; Patel NM; Kalaskar DM; Mosahebi A; Mehrara BJ; Seifalian AM
J Surg Res; 2014 Dec; 192(2):544-54. PubMed ID: 25248852
[TBL] [Abstract][Full Text] [Related]
20. In vivo vascularized scaffold with different shear-exposed models for lymphatic tissue regeneration.
Hsiao HY; Mackert GA; Chang YC; Liu JW; Chang FC; Huang JJ
J Tissue Eng; 2023; 14():20417314231196212. PubMed ID: 37661967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
